Cargando…

Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease

Chronic kidney disease (CKD) is a slow-developing, progressive deterioration of renal function. The final common pathway in the pathophysiology of CKD involves glomerular sclerosis, tubular atrophy and interstitial fibrosis. Transforming growth factor-beta (TGF-β) stimulates the differentiation of f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerrits, Tessa, Brouwer, Isabella J., Dijkstra, Kyra L., Wolterbeek, Ron, Bruijn, Jan A., Scharpfenecker, Marion, Baelde, Hans J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820946/ https://www.ncbi.nlm.nih.gov/pubmed/36614087 http://dx.doi.org/10.3390/ijms24010646

Ejemplares similares

Endoglin Promotes Myofibroblast Differentiation and Extracellular Matrix Production in Diabetic Nephropathy
por: Gerrits, Tessa, et al.
Publicado: (2020)

The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
por: Bus, Pascal, et al.
Publicado: (2017)

Glomerular clusterin expression is increased in diabetic nephropathy and protects against oxidative stress-induced apoptosis in podocytes
por: He, Junling, et al.
Publicado: (2020)

Endothelial Endothelin Receptor A Expression Is Associated With Podocyte Injury and Oxidative Stress in Patients With Focal Segmental Glomerulosclerosis
por: van de Lest, Nina A., et al.
Publicado: (2021)

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022)

Nephrin Loss Can Be Used to Predict Remission and Long-term Renal Outcome in Patients With Minimal Change Disease
por: van de Lest, Nina A., et al.
Publicado: (2017)

The roles of endoglin gene in cerebrovascular diseases
por: Zhu, Wan, et al.
Publicado: (2017)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

Endoglin: Beyond the Endothelium
por: Schoonderwoerd, Mark J. A., et al.
Publicado: (2020)

Reducing YAP expression in Pkd1 mutant mice does not improve the cystic phenotype
por: Formica, Chiara, et al.
Publicado: (2020)

MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2012)

Complement Activation in Patients With Diabetic Nephropathy
por: Bus, Pascal, et al.
Publicado: (2017)

Circulating Endoglin Concentration Is Not Elevated in Chronic Kidney Disease
por: Charytan, David M., et al.
Publicado: (2011)

Editorial: Role of membrane-bound and circulating endoglin in disease
por: Bernabeu, Carmelo, et al.
Publicado: (2023)

Endoglin and squamous cell carcinomas
por: Hakuno, Sarah K., et al.
Publicado: (2023)

The Role of Endoglin in Hepatocellular Carcinoma
por: Jeng, Kuo-Shyang, et al.
Publicado: (2021)

Endoglin in the Spotlight to Treat Cancer
por: González Muñoz, Teresa, et al.
Publicado: (2021)

Endoglin in head and neck neoplasms
por: Litwiniuk-Kosmala, Małgorzata, et al.
Publicado: (2023)

Monocytic cell junction proteins serve important roles in atherosclerosis via the endoglin pathway
por: Chen, Lina, et al.
Publicado: (2017)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease
por: Turner, R. J., et al.
Publicado: (2016)

Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling
por: Kumar, S, et al.
Publicado: (2014)

Endoglin: a critical mediator of cardiovascular health
por: Kapur, Navin K, et al.
Publicado: (2013)

Endoglin Targeting: Lessons Learned and Questions That Remain
por: Liu, Yingmiao, et al.
Publicado: (2020)

Endoglin and TGF-β signaling in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021)

Evaluation of endocan and endoglin levels in chronic kidney disease due to diabetes mellitus
por: Ekiz-Bilir, Betül, et al.
Publicado: (2018)

Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review
por: Sier, Vincent Q., et al.
Publicado: (2021)

Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies
por: Nolan-Stevaux, Olivier, et al.
Publicado: (2012)

Endoglin integrates BMP and Wnt signalling to induce haematopoiesis through JDP2
por: Baik, June, et al.
Publicado: (2016)

Contrasting Roles of Different Endoglin Forms in Atherosclerosis
por: Jang, Young-Saeng, et al.
Publicado: (2014)

The Role of the TGF-β Coreceptor Endoglin in Cancer
por: Pérez-Gómez, Eduardo, et al.
Publicado: (2010)

Role of soluble endoglin in BMP9 signaling
por: Lawera, Aleksandra, et al.
Publicado: (2019)

Structural and Functional Insights into Endoglin Ligand Recognition and Binding
por: Alt, Aaron, et al.
Publicado: (2012)

Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage
por: Garzon-Martinez, Mercedes, et al.
Publicado: (2020)

Increased dynamin expression precedes proteinuria in glomerular disease
por: Khalil, Ramzi, et al.
Publicado: (2018)

Editorial: The Physiology of Inflammation—The Final Common Pathway to Disease
por: Mendes, Alexandrina Ferreira, et al.
Publicado: (2018)

A Single Sphingomyelin Species Promotes Exosomal Release of Endoglin into the Maternal Circulation in Preeclampsia
por: Ermini, Leonardo, et al.
Publicado: (2017)

Endoglin modulates cellular responses to TGF-beta 1
Publicado: (1996)

Endoglin regulates mural cell adhesion in the circulatory system
por: Rossi, Elisa, et al.
Publicado: (2015)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7eoftjmv9elq67216qq0dr2fu5